Volver a Agenda
Session Chair(s)
Karen Midthun, MD
Principal, Drug and Biological Products
Greenleaf Health, United States
Learning Objective : Summarize key issues discussed by CBER; Identify regulatory hot topics in biologics.
Speaker(s)
Panelist
Robert A. Yetter, PHD
FDA, United States
Associate Director for Review Management, Office of the Director, CBER
¿Tiene una cuenta?